Form 8-K - Current report:
SEC Accession No. 0001564590-18-000312
Filing Date
2018-01-09
Accepted
2018-01-09 16:15:19
Documents
3
Period of Report
2018-01-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K HEPLISAV-B LAUNCH dvax-8k_20180108.htm 8-K 24172
2 EX-99.1 dvax-ex991_6.htm EX-99.1 26323
3 GRAPHIC g201801082320221603180.jpg GRAPHIC 3968
  Complete submission text file 0001564590-18-000312.txt   57227
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 18519218
SIC: 2834 Pharmaceutical Preparations